Review of biologics, biosimilars, and intended copies in rheumatology, and current practice in Iraq

Biologic therapies are an important option in the treatment of patients with rheumatic disease. As the development of potential biosimilars increases, many countries are following the guidelines developed by the WHO, European Medicines Agency, or US Food and Drug Administration to create country-spe...

Descripción completa

Detalles Bibliográficos
Autores principales: Al Ani, Nizar Abdulateef, Gorial, Faiq I, Al-Sulaitti, Saad, Humadi, Jasmine Abbas, Awadh, Nabaa Ihsan, Mounir, Mohamed, Dershaby, Yasser El, Jones, Heather, Sunna, Nancy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307490/
https://www.ncbi.nlm.nih.gov/pubmed/30613169
http://dx.doi.org/10.2147/OARRR.S176965

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6307490/
https://www.ncbi.nlm.nih.gov/pubmed/30613169
http://dx.doi.org/10.2147/OARRR.S176965

Ejemplares similares